ReproCELL Incorporated
4978.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | ¥498 | ¥476 | ¥910 | ¥748 |
| % Growth | 4.7% | -47.7% | 21.6% | – |
| Cost of Goods Sold | ¥306 | ¥282 | ¥381 | ¥336 |
| Gross Profit | ¥192 | ¥194 | ¥529 | ¥412 |
| % Margin | 38.5% | 40.7% | 58.1% | 55.1% |
| R&D Expenses | ¥146 | ¥162 | ¥171 | ¥129 |
| G&A Expenses | ¥0 | ¥0 | ¥59 | ¥0 |
| SG&A Expenses | ¥301 | ¥322 | ¥308 | ¥315 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥233 | ¥0 |
| Other Operating Expenses | ¥0 | ¥0 | ¥0 | -¥1 |
| Operating Expenses | ¥447 | ¥485 | ¥479 | ¥443 |
| Operating Income | -¥256 | -¥291 | ¥50 | -¥31 |
| % Margin | -51.3% | -61.2% | 5.5% | -4.1% |
| Other Income/Exp. Net | ¥74 | -¥11 | ¥28 | ¥102 |
| Pre-Tax Income | -¥182 | -¥302 | ¥78 | ¥71 |
| Tax Expense | ¥0 | ¥2 | -¥56 | -¥2 |
| Net Income | -¥182 | -¥304 | ¥134 | ¥73 |
| % Margin | -36.5% | -64% | 14.8% | 9.8% |
| EPS | -1.92 | -3.21 | 1.42 | 0.78 |
| % Growth | 40.2% | -326.1% | 82.1% | – |
| EPS Diluted | -1.92 | -3.21 | 1.42 | 0.78 |
| Weighted Avg Shares Out | 95 | 95 | 94 | 94 |
| Weighted Avg Shares Out Dil | 95 | 95 | 94 | 94 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥25 | ¥17 | ¥24 | ¥13 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥18 | ¥17 | ¥15 | ¥9 |
| EBITDA | -¥164 | -¥285 | ¥93 | -¥23 |
| % Margin | -32.9% | -60% | 10.2% | -3.1% |